Filter
14862
Filtered Results: 14862
Text search:
WHO
(
World
Health
Organization)
Featured
Recommendations
1343
New Publications
3363
Language
Document type
No document type
7301
Studies & Reports
2527
Guidelines
1895
Manuals
719
Fact sheets
639
Strategic & Response Plan
537
Training Material
305
Situation Updates
264
Resource Platforms
174
Infographics
170
Online Courses
120
Videos
95
Brochures
67
Dashboards/Maps
36
App
13
Countries / Regions
Global
782
India
486
Kenya
339
Sierra Leone
288
Nigeria
260
Liberia
254
Uganda
253
Ethiopia
251
South Africa
241
Western and Central Europe
240
Nepal
226
Latin America and the Carribbean
212
Myanmar / Burma
201
Syria
197
Africa
193
Rwanda
178
Bangladesh
176
Zambia
174
Russia
173
Ukraine
171
Tanzania
165
Malawi
163
Congo, Democratic Republic of
154
Ghana
145
Namibia
127
Mozambique
118
Philippines
111
Eastern Europe
110
South Sudan
110
Indonesia
106
Brazil
104
Middle East and North Africa
100
South–East Asia Region
90
Lesotho
89
West and Central Africa
89
Yemen
89
Guinea
86
Zimbabwe
85
Senegal
84
Haiti
82
Cambodia
82
Germany
74
East and Southern Africa
74
Asia
69
Venezuela
66
Burkina Faso
62
Colombia
56
Cameroon
55
Eastern Europe and Central Asia
53
Botswana
52
Pakistan
43
Angola
42
Eswatini/ Swaziland
40
Mali
39
Madagascar
39
Afghanistan
37
Sudan
37
Benin
35
China
34
Paraguay
34
Central African Republic
34
Somalia
32
Lebanon
31
Vietnam
29
Jordan
28
Western Pacific Region
28
Côte d’Ivoire / Ivory Coast
27
Thailand
26
Guinea-Bissau
26
Tajikistan
25
Niger
23
Peru
23
Iraq
21
Turkey
20
Argentina
20
Sri Lanka
20
Chad
20
Moldova
19
North America
18
Laos
17
Chile
16
Albania
16
USA
15
Georgia
15
Kazakhstan
13
Ecuador
13
Mexico
12
Togo
12
Iran
12
Kyrgyzstan
12
Burundi
12
Armenia
12
Spain
12
Palestine
12
Libya
12
Bolivia
11
Egypt
11
North Macedonia
10
Saudi Arabia
10
Portugal
10
Belarus
10
Greece
10
Papua New Guinea
9
Romania
9
Timor Leste/ East Timor
8
El Salvador
8
Southern Africa
8
Gambia
7
Malaysia
7
Tunisia
7
Poland
7
Honduras
7
Bhutan
7
Guatemala
7
Serbia
6
Jamaica
6
Japan
6
Estonia
5
Uzbekistan
5
Morocco
5
Hungary
5
Turkmenistan
5
France
5
Azerbaijan
5
Fiji
4
Congo-Brazzaville
4
Mauritania
4
Italy
4
United Kingdom
4
Nicaragua
4
Djibouti
4
Switzerland
3
Canada
3
Singapore
3
Mongolia
3
Qatar
3
Dominican Republic
3
Croatia
3
Gabon
3
Uruguay
3
Mauritius
3
Israel
3
Bosnia and Herzegovina
3
North Korea
2
Vanuatu
2
Bulgaria
2
Lithuania
2
Ireland
2
Denmark
2
Algeria
2
Slovakia
2
Cuba
2
Australia
1
Cape Verde
1
Belgium
1
Maldives
1
Norway
1
South Korea
1
Morocco
1
Latvia
1
Barbados
1
Belize
1
Costa Rica
1
Eritrea
1
Guyana
1
Panama
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
5065
Clinical Guidelines
997
Key Resources
811
Public Health
792
Women & Child Health
724
Capacity Building
332
Pharmacy & Technologies
148
Annual Report MEDBOX
3
Toolboxes
COVID-19
1698
Mental Health
1090
HIV
1002
TB
759
Disability
607
NTDs
602
Planetary Health
518
Ebola & Marburg
493
AMR
410
Caregiver
409
Conflict
400
NCDs
375
Rapid Response
327
Refugee
272
Global Health Education
266
Pharmacy
222
Malaria
208
Natural Hazards
187
Health Financing Toolbox
186
Zika
160
2.0 Rapid Response
139
Cholera
128
Specific Hazards
82
Polio
82
Social Ethics
57
Typhoon
8
South Sudan
2
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
The Contingency Fund for Emergencies (CFE) provides WHO with rapid and flexible resources to respond to disease outbreaks and other health emergencies. The annual report provides an overview of the use and impact of the Fund over the previous year.
The following protocol has been designed to investigate the First Few X cases (FFX) and their close contacts. It is envisioned that the FFX 2019-nCoV investigation will be conducted across several countries or sites with geographical and demographical diversity. Using a standardized protocol such a...
Caring for burns patients from the incident scene to definitive treatment can be a complex, resource-consuming process with the potential to overwhelm health system capacity.This document provides practical guidance for building capacity and capability for burns care from clinical, human resources a...
Contact tracing is a key element of WHO’s recommended approach to control the spread of COVID-19 by breaking the chains of human-to-human transmission.
This document provides guidance to health authorities at all levels to improve the success rate of contact tracing by informing efforts with RCCE...
Cholera is a major health risk in many parts of the world, affecting millions of people every year. Since mid-2021, the world has been facing an acute upsurge of the 7th cholera pandemic, which is characterized by the number, size and concurrence of multiple outbreaks, the spread to areas that had b...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
The purpose of this document is to present and promote the minimum requirements for IPC programmes at the national and health care facility level, identified by expert consensus according to available evidence and in the context of the WHO core components.
The minimum requirements are defined as: I...
Countries are making progress toward the global goal of 95% of people living with HIV knowing their status by 2025. However, considerable gaps remain in achieving these goals globally. Men in high HIV burden settings and men from key populations in all settings are consistently less likely to know t...
This toolkit is a "how to" guide for developing, implementing and evaluating a multisectoral action plan for prevention and control of NCDs. It is targeted at policy-makers, planners and programme managers, and is intended to help countries, provinces and cities meet the requirements for achieving g...
At the threshold of Sustainable Development Goals (SDG) era, this document captures the remarkable achievements by Member States towards achieving MDGs 4 and 5. It acknowledges new opportunities in the post-2015 phase shaped by the SDGs and the Global Strategy for women’s, children’s and adoles...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
A study conducted by the World Health Organisation Regional Office for Africa. The COVID-19 pandemic has had a significant impact on older persons both globally and in the African region. Although overall the region’s population is younger relative to many other world regions, the WHO AFRO region ...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
recommended
Guidance has been updated on a number of chemicals: asbestos, bentazone, chromium, iodine, manganese, microcystins, nickel, silver, tetrachloroethene and trichloroethene. Guidance has also been added for chemicals not previously assessed in the Guidelines: anatoxin-a and analogues, cylindrospermopsi...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
